Clinical trials for next-generation drugs should be patient-centric – STAT
In designing next-generation clinical trials, it is important to emphasize the broader needs of the patients taking part in them.
Related Articles
After FDA rejection, Sanofi and Regeneron’s Dupixent succeeds in late-stage trial of chronic hives
Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with an inflammatory skin disease in a late-stage trial.
AI threatens to cement racial bias in clinical algorithms. Could it also chart a path forward?
The most alarming thing about AI isn’t its newness: It’s that it repeats an age-old mistake in medicine, continuing to use flawed, incomplete data to…
Trump struggles to find an abortion answer
Harris hammered Trump for his shifting stance on abortion, as the former president tried to satisfy moderate voters and his party’s anti-abortion contingent.
Key lawmakers are wary of giving FDA more cash to crack down on e-cigs
The situation presents a Catch-22 for the FDA, which says it needs more funds to police illegal vapes.
Elevance buys IU Health’s insurance company
Hospitals systems are giving up on the idea that they can be your insurance company, too.
Obesity drug worked in children ages 6 to 12, study says, raising hopes and concerns
The first trial of a GLP-1 in children 6-12 showed it was effective, but raises questions about whether the benefits of weight loss justify giving…
Novo Nordisk’s amylin pill leads to substantial weight loss in early study
Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation candidates.
Biden administration finalizes rules to ensure insurers pay for mental health care
The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to force health insurers to cover mental health care on
The health care issues to watch in tonight’s presidential debate between Kamala Harris and Donald Trump
Harris and Trump have thrown campaign trail barbs about reproductive rights, the future of Medicare, and who did what to lower Americans’ drug costs. Tonight,…
Trump keeps losing his train of thought. Cognitive experts have theories about why
Shifting from topic to topic, with few connections, is one of several disjointed and occasionally incoherent verbal habits that seem to have increased in Trump’s…